Received Mar 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | — | — |
adult patients but receiving all their pediatric vaccines; Pediatric vaccine to an adult patient/ using vaccine off label; Pediatric vaccine to an adult patient/ using vaccine off label; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of underdose in an unspecified number of patients who received Men ACWY-CRM NVS (Menveo) for prophylaxis. The patient's past medical history included stem cell transplant. On an unknown date, the patient received Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced underdose (Verbatim: adult patients but receiving all their pediatric vaccines), adult use of a child product (Verbatim: Pediatric vaccine to an adult patient/ using vaccine off label) and off label use (Verbatim: Pediatric vaccine to an adult patient/ using vaccine off label). The outcome of the underdose, adult use of a child product and off label use were not applicable. Additional Information: GSK Receipt Date: 20-FEB-2025 The reporter reported the post stem cell transplant patients receive all their childhood vaccines again after transplant. They were vaccinated like a pediatric patient. And were unsure if they require the 2 vial presentation or 1 vial presentation. These were adult patients but receiving all their pediatric vaccines which led to underdose, adult use of a child product and off label use. All of adult patients were receiving the 2 vial presentation. Health care professional did not mentioned how many patients nor any patient information. Even that health care professional mentioned that they administer the Menveo 2 vial.
Medical History/Concurrent Conditions: Stem cell transplant